Detailed Programme - 18 June 2025

Time	Session

08:30 09:15	EditCo Bio: Uncovering Novel Cancer Therapeutic Targets: Accelerating Discovery Through Streamlined CRISPR Cell Engineering HardcastleTravis Industry Moderator/ Chair United States Introduction HardcastleTravis Industry Moderator/ Chair United States Unveiling SURF2’sRole in Nucleolar Stress and Its Potential as a Therapeutic Target LebaronSimon Industry Speaker France AI-driven identification and validation of novel synthetic lethal gene pairs MillerDaniel Industry Speaker United Kingdom Leveraging an advanced CRISPR platform to streamline oncology breakthroughs SoenensAmalia Industry Speaker Auditorium 2		Arima Genomics: Transposable elements reorganise the 3D genome structure in CDK4/6 inhibitors resistant breast cancer Transposable elements reorganise the 3D genome structure in CDK4/6 inhibitors resistant breast cancer. Achinger-KaweckaJoanna Industry Speaker Australia Auditorium 6+7		Meet the Expert - Interactive Session TrumppAndreas Moderator Germany Advancing Science Through Industry-Academic Collaboration: Pre-Clinical Development of KRAS Modulators HofmannMarco Speaker Austria Tumor Archetypes Reimagined: Multi-Omic Insights, AI-Driven Discovery, and New Frontiers in Cancer Subtyping SinaNassiri Speaker Switzerland Discussion with the Experts Career Discovery Area
09:20 10:55	Symposium: New Drugs on the Horizon WestermarckJukka Co-Chair Finland CaffarelMaria M. Co-Chair Spain Drugging transcription factors: HSF1 and Brachyury WorkmanPaul Speaker United Kingdom Proffered Paper: Selected from Abstracts - to be announced in 2025 Targeting chromatin proteins for therapeutic benefit in haematological malignancy SomervailleTim Speaker United Kingdom Proffered Paper: Selected from Abstracts - to be announced in 2025 PP2A inhibitor protein CIP2A is a prime target for TNBC therapy WestermarckJukka Speaker Finland Auditorium 1		Symposium: Tumour Innervation BaggioliniArianna Co-Chair Switzerland WinklerFrank Co-Chair Germany The neural regulation of small cell lung cancer progression VenkateshHumsa Speaker United States Proffered Paper: Selected from Abstracts - to be announced in 2025 Neural mechanisms of brain tumor growth and resistance WinklerFrank Speaker Germany Proffered Paper: Selected from Abstracts - to be announced in 2025 Neural-tumour communication accelerates cancer progression and impairs treatment response SloanErica Speaker Australia Auditorium 2		Symposium: Normal Tissue (not Blood) SalvadorBeatriz Co-Chair United Kingdom RisquesRosana Co-Chair United States Clonal evolution of cancer from initiation to metastasis in the mouse (REMOTE Presentation) BalmainAllan Speaker United States Proffered Paper: Selected from Abstracts - to be announced in 2025 Mutational landscape and clonal dynamics in normal and precancerous tissues RahbariRaheleh Speaker United Kingdom Proffered Paper: Selected from Abstracts - to be announced in 2025 Somatic evolution in normal tissues and cancer risk RisquesRosana Speaker United States Auditorium 6+7
10:45 11:35	Coffee Break / Exhibition/ Industry Spotlight Poster and Exhibition Hall
11:15 11:30	TECAN Industry Spotlight: TECAN: Label-free spheroids and organoids analysis for assays development VettoreNicola Industry Speaker Germany Spotlight Area
11:35 13:10	Symposium: Cancer Genomics CaldasCarlos Co-Chair United Kingdom NagarajanSankari Co-Chair United Kingdom Epigenetic dysregulation and cancer evolution ScaffidiPaola Speaker Italy Proffered Paper: Selected from Abstracts - to be announced in 2025 EMBO Young Investigator Lecture: Cancer aneuploidy - From evolutionary pressures to cellular vulnerabilities Ben-DavidUri Speaker Israel Proffered Paper: Selected from Abstracts - to be announced in 2025 Title to be announced TurajlicSamra Speaker United Kingdom Auditorium 1	Joint EACR - EMBO Symposium: Advanced in vitro Models ChumduriCindrilla Co-Chair Denmark BernardsRene Co-Chair Netherlands Cell plasticity in human colon and cancer SnippertHugo Speaker Netherlands Proffered Paper: Selected from Abstracts - to be announced in 2025 Development of advanced immunotherapies using human 3D-bioprinted cancer avatars Satchi-FainaroRonit Speaker Israel Proffered Paper: Selected from Abstracts - to be announced in 2025 Deciphering the role of infection and diet in driving early carcinogenic events using advanced organoid models and omics ChumduriCindrilla Speaker Denmark Auditorium 2		Joint EACR - ASPIC Symposium: Cancer Therapy Resistance AmbrogioChiara Co-Chair Italy MeloLuise Co-Chair Portugal Studying melanoma therapy resistance one cell at the time MarineJean-Christophe Speaker Belgium Proffered Paper: Selected from Abstracts - to be announced in 2025 The role of RANK signaling in breast cancer biology and response to therapy CasimiroSandra Speaker Portugal Proffered Paper: Selected from Abstracts - to be announced in 2025 Mechanism of response and resistance to RAS inhibition in solid tumors MisaleSandra Speaker United States Auditorium 6+7		Symposium: Tumour Dormancy BoitorAlexandra Co-Chair United Kingdom Luisa CorreiaAna Co-Chair Portugal Unravelling mechanisms of ER+ Breast cancer dormancy GomisRoger Speaker Spain Proffered Paper: Selected from Abstracts - to be announced in 2025 What makes a tissue favorable or not to metastasis? Luisa CorreiaAna Speaker Portugal Proffered Paper: Selected from Abstracts - to be announced in 2025 How host niche variations regulate disseminated cancer cell dormancy and awakening Aguirre-GhisoJulio A. Speaker United States Auditorium 8
13:15 15:15	Lunch Break / Exhibition / Poster Viewing Poster and Exhibition Hall
13:30 14:15	Akoya Biosciences, Inc.: Scaling Immuno-Oncology Research with IO60: The Fastest UltraHigh-Plex Spatial Proteomics Panel Auditorium 2		Illumina: Unlocking the Power of Single-Cell and Spatial Multiomics for Cancer Research Introducing Illumina Single Cell and Spatial Technology MishraVivek Kumar Industry Moderator/ Chair Germany Scalable single-cell RNA profiling of pooled CRISPR screens discloses novel biology of cancer and T cells Cell Altasing Human Intestine using Illumina Spatial Technology ZhuChenchen Industry Speaker United States Illumina Connected Multiomics ScmidJoachim Industry Speaker Germany Auditorium 6+7		QIAGEN: Immune competence and tumor-specific response of Vδ1 T cells in endometrial cancer: Implications for PD-1 blockade therapy Immune competence and tumor-specific response of Vδ1 T cells in endometrial cancer: Implications for PD-1 blockade therapy MikulakJoanna Industry Speaker Italy Auditorium 8
13:30 14:15	Career Discovery Session 2A (open to EACR Early Career & Student Members, pre-registration required) CarracedoArkaitz Coordinator Spain OricchioElisa Coordinator Switzerland TABLE 1: How to build your own network RisquesRosana Moderator United States TABLE 2: Leadership: Experience in combining research with the direction of a research institute BardelliAlberto Moderator Italy TABLE 3: Leadership: Experience as a team leader and a research center science director MarineJean-Christophe Moderator Belgium TABLE 4: Life of a scientist between research and hospital SomervailleTim Moderator United Kingdom TABLE 5: How to make your research impactful and transferable to the clinic GomisRoger Moderator Spain TABLE 6: How to build a successful lab environment WestermarckJukka Moderator Finland TABLE 7: How do you know when you are ready to start your own lab? TurajlicSamra Moderator United Kingdom TABLE 8: Challenges of setting up a new lab and establishing yourself as a PI in your home country after years abroad Luisa CorreiaAna Moderator Portugal TABLE 9: The challenges of starting your own lab VenkateshHumsa Moderator United States TABLE 10: ERC funding opportunities for starting or establishing a research group in the EU or Associated Countries Veronica Caraffini Moderator Career Discovery Area
14:25 15:15	Career Discovery Session 2B (open to EACR Early Career & Student Members, pre-registration required) CarracedoArkaitz Coordinator Spain OricchioElisa Coordinator Switzerland TABLE 1: A career at the intersection between cell biology and oncology RegenbergBirgitte Moderator Denmark TABLE 2: Navigating a career in Academia and Industry PaganiMassimiliano Moderator Italy TABLE 3: Challenges of being a clinician scientist: Successfully balancing clinical and academic duties TaberneroJosep Moderator Spain TABLE 4: From fundamental science to translational impact TABLE 5: A career in computational biology TABLE 6: Challenges of establishing your lab in an unstable socio-political climate Ben-DavidUri Moderator Israel TABLE 7: Current challenges in academia: tips to survive Aguirre-GhisoJulio A. Moderator United States TABLE 8: The challenges of starting your own lab MisaleSandra Moderator United States TABLE 9: Leadership: Experience of a former EACR president BernardsRene Moderator Netherlands TABLE 10: From performing research to supporting researchers: transitioning from academia to scientific administration Veronica Caraffini Moderator Career Discovery Area
14:30 15:15	Olink, part of Thermo Fisher Scientific: Plasma Proteomics: Driving a New Era for Cancer Research and Precision Medicine RUCEVICGuyonnetMarijana Industry Moderator/ Chair Sweden Olink Proteomics: Accelerating progress in cancer research and the path to therapeutics RUCEVICGuyonnetMarijana Industry Speaker Sweden Deep plasma proteomics identifies and validates an eight-protein biomarker panel for ovarian cancer EnrothStefan Industry Speaker Sweden Liquid biopsy: Plasma proteomics to identify novel biomarkers ItalianoAntoine Industry Speaker France Questions and Answers Auditorium 2		NVision Imaging Technologies: Hyperpolarized MRI agents: imaging metabolic flux in vivo TBC BennettSimon Industry Speaker Germany TBC ChaumeilM.Myriam Industry Speaker Germany Auditorium 6+7		Oxford Nanopore Technologies: Deciphering Cancer Evolution and Progression with Multiomic Single Cell Insights Juarez Eleonora Industry Moderator/ Chair United States Introduction Juarez Eleonora Industry Moderator/ Chair United States Bridging genotype and phenotype through single-cell and single-molecule multi-omics Tumour heterogeneity and clonal selection of ecDNA at single-cell level Deleuran Hendriksen Josephine Industry Speaker Denmark Auditorium 8
15:20 16:55	Symposium: AI Tools in Cancer Research CaldasCarlos Co-Chair United Kingdom JacquemetGuillaume Co-Chair Finland Agent-Based Modelling of Gene Networks the tumour microenvironment ecosytem BuffaMeteoraFrancesca Speaker United Kingdom Proffered Paper: Selected from Abstracts - to be announced in 2025 New Insights into the Impact of the Tumor Microbiome on Immunotherapy Response LitchfieldKevin Speaker United Kingdom Proffered Paper: Selected from Abstracts - to be announced in 2025 Title to be announced McGranahanNicholas - Speaker (TBI) United Kingdom Auditorium 1	Symposium: Prevention and Early Detection LimEmilia Co-Chair Canada SoengasMarisol S. Co-Chair Spain Polygenic risk models and prevention in breast and ovarian cancer PharoahPaul Speaker United States Proffered Paper: Selected from Abstracts - to be announced in 2025 Mechanisms of Lung Cancer Promotion HillWilliam Speaker United Kingdom Proffered Paper: Selected from Abstracts - to be announced in 2025 Investigating the impact of environmental exposures LimEmilia Speaker Canada Auditorium 2		Symposium: DNA Repair and Immunosurveillance BardelliAlberto Co-Chair Italy DiazLuis Alberto Co-Chair United States DNA repair-dependent immunogenic liabilities in colorectal cancer: the opportunity comes from the errors GermanoGiovanni Speaker Italy Proffered Paper: Selected from Abstracts - to be announced in 2025 Immunoprevention in Lynch Syndrome DiazLuis Alberto Speaker United States Proffered Paper: Selected from Abstracts - to be announced in 2025 Title to be announced PaganiMassimiliano Speaker Italy Auditorium 6+7		Symposium: EC DNA DiveCaroline Co-Chair United Kingdom dos Santos DiasMatheus Co-Chair The Netherlands Extrachromosomal DNA (ecDNA): Cancer’s Dynamic Circular Genome MischelPaul Salomon Speaker United States Proffered Paper: Selected from Abstracts - to be announced in 2025 Functional Role of Extrachromosomal Circular DNA in Colorectal, Renal and Bladder Cancers RegenbergBirgitte Speaker Denmark Proffered Paper: Selected from Abstracts - to be announced in 2025 A general strategy to model ecDNA-mediated focal amplifications in cells and in mice VenturaAndrea Speaker Auditorium 8
16:55 18:30	Coffee Break / Exhibition / Industry Spotlight Poster and Exhibition Hall
17:15 17:30	Cellecta Inc. Industry Spotlight
17:30 18:15	Plenary Session - From Bench to Bedside and Back BardelliAlberto Chair Italy BernardsRene Co-Chair Netherlands Clinical findings in preclinical perspective BardelliAlberto Speaker Italy BernardsRene Speaker Netherlands Introduction on PFS and OS of the BREAKWATER study (1st line) TaberneroJosep Speaker Spain Clinical Development Saoudi GonzálezNadia Speaker Italy Auditorium 1
18:15 18:40	Posters in the Spotlight - Wednesday Spotlight Area
18:40 20:00	Poster Defence Session - Wednesday
10:45 20:00	Poster Session Wednesday Poster and Exhibition Hall